Research Blogs

Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung

Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss

Read time: 3 minutes. For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are

Read time: 2 minutes. The annual World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer, is the largest global meeting

Read time: 3 minutes. Small cell lung cancer (SCLC) research continues to progress at an unprecedented rate. Exciting news emerged from the 2025 World Congress on Lung Cancer, with

Read time: 2 minutes. Of the more than 234,000 people who will be diagnosed with lung cancer in 2025, roughly 50% are ineligible for lung cancer screening according to current

Read time: 3 minutes. As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked

Read time: 4 minutes. As a dedicated researcher and oncologist, Noura Choudhury, MD, at the University of Chicago, witnesses daily the urgent need for better treatments for lung

Read time: 3 minutes. When Erin Schenk, MD, PhD, began her journey as a junior faculty member at the University of Colorado, she treated patients with various types of lung cancer

Read time: 2 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts

Read time: 9 minutes. The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May

Read time: 2 minutes. When a person is treated for advanced-stage lung cancer, tumors will often shrink, and their symptoms may subside. An effective treatment will kill many tumor